Fig. 1
From: Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy
Total IgM and IgG titers following B cell depletion therapy. Longitudinal antibody titers are shown for RA (red), PV (yellow), AAV (green), and MS (pink). A Total IgM levels (g/L) at 0, 6, and 12 months after initiation of B cell depletion therapy. Connected dots represent a patient. Grey area indicates normal range: 0.4–2.3 g/L IgM. B. Total IgG (g/L) as measured at 0, 6, and 12 months after start B cell depletion therapy. Grey area indicates normal range: 7–16 g/L. Statistical differences were determined using a Wilcoxon matched-pairs signed rank test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
